These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19800440)

  • 1. Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study.
    Dommergues MA; de La Rocque F; Guy C; Lécuyer A; Jacquet A; Guérin N; Fagot JP; Boucherat M; d'Athis P; Cohen R
    Vaccine; 2009 Nov; 27(50):6967-73. PubMed ID: 19800440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [French survey about intradermal BCG SSI adverse events in children under 6 years of age].
    Dommergues MA; de la Rocque F; Dufour V; Floret D; Gaudelus J; Guérin N; Le Sage FV; Bocquet A; Cohen R
    Arch Pediatr; 2007 Jan; 14(1):102-8. PubMed ID: 17140780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
    Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
    Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002.
    Roth A; Sodemann M; Jensen H; Poulsen A; Gustafson P; Gomes J; Djana Q; Jakobsen M; Garly ML; Rodrigues A; Aaby P
    Vaccine; 2005 Jun; 23(30):3991-8. PubMed ID: 15899539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National study of adverse reactions after vaccination with bacille Calmette-Guérin.
    Turnbull FM; McIntyre PB; Achat HM; Wang H; Stapledon R; Gold M; Burgess MA
    Clin Infect Dis; 2002 Feb; 34(4):447-53. PubMed ID: 11797170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV-infection, AIDS and BCG vaccination].
    Toida I
    Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen.
    Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Quast U; Widmark RM
    Dev Biol Stand; 1979; 43():133-6. PubMed ID: 520665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of BCG vaccination; mainly BCG infection.
    Prescrire Int; 2003 Dec; 12(68):220-4. PubMed ID: 14986693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J; O'Connor ME
    Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG vaccine-associated suppurative lymphadenitis.
    Teo SS; Smeulders N; Shingadia DV
    Vaccine; 2005 Apr; 23(20):2676-9. PubMed ID: 15780451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell mediated immunity in children with scar-failure following BCG vaccination.
    Rani SH; Vijayalakshmi V; Sunil K; Lakshmi KA; Suman LG; Murthy KJ
    Indian Pediatr; 1998 Feb; 35(2):123-7. PubMed ID: 9707854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Causes of ineffectiveness of BCG vaccination and its impact on childhood tuberculosis].
    Ivan'kova VS; Ivanova NF
    Probl Tuberk; 1990; (9):20-1. PubMed ID: 2274500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes.
    Gonzalez B; Moreno S; Burdach R; Valenzuela MT; Henriquez A; Ramos MI; Sorensen RU
    Pediatr Infect Dis J; 1989 Apr; 8(4):201-6. PubMed ID: 2654859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination of newborns with high risk of tuberculosis in a French maternity hospital].
    Dommergues MA; Robichon F; Soltane S; Refol S; Panel P; Foucaud P
    Arch Pediatr; 2009 Sep; 16(9):1270-5. PubMed ID: 19632818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse events following BCG vaccination].
    Sagić L
    Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.